349 cases of Covid's XBB1.16 strain: symptoms and severity

349 cases of Covid's XBB1.16 strain: symptoms and severity

According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), which was cited by news agency PTI, 349 new cases of the XBB1.16 variant, which may have been responsible for the recent rise in coronavirus cases, have been discovered in India, where Covid-19 infections are increasing on a daily basis.

According to INSACOG data received by PTI, Maharashtra has the most instances of the XBB1.16 variety with 105 cases, followed by Telangana with 93 cases, Karnataka with 61 cases, and Gujarat with 54 cases.

The so-called most contagious XBB 1.16 variation was discovered in India for the first time in January of this year when two samples tested positive for the variant. 140 samples of the XBB 1.16 variant were detected in February. The results showed that as of today, 207 examples of the XBB 1.16 variation had been discovered.

How does XBB 1.16 variation work?

Given how quickly it is spreading and how infectious it is, this new strain is being seen as a danger. A recombinant lineage of the virus known as XBB.1.16 is a progeny of the XBB lineage of Covid-19.

XBB.1.16, a mutant strain of SARS CoV 2 that mostly affects Omicron, may cleverly evade immunization, according to a number of health specialists. Even before it appeared in late 2021, the Omicron version was renowned for its rapid transmission rate.


As of right now, it doesn't seem that the XBB.1.16 variation is really harming anyone's health. Upper respiratory problems including a clogged nose, headache, and sore throat are typical symptoms, coupled with a fever and myalgia, or muscular discomfort, that lasts for three to four days.

located in 12 nations:

The novel XBB.1.16 variety has reportedly been found in at least 12 countries, with India having the largest number of instances, followed by the US, Brunei, Singapore, and the UK, according to Vipin M. Vashishtha, consultant pediatrician at the Mangla Hospital and Research Centre, Bijnor.

Dr. Randeep Guleria, a former director of AIIMS who oversaw the national Covid task group, said that the XBB 1.16 mutation seems to be the primary cause of the increase in Covid cases. He stated: "Following Covid-appropriate behavior may limit the transmission of infection for any of these situations. And also most of the instances are not serious; thus there is no reason to fear as of now".

The number of Covid cases in India rose by 1,300 on Thursday, the most in 140 days, and the number of active cases rose to 7,605 as a result.